InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...
The following is a summary of “Predictive Factors in Asymptomatic Bacteriuria Treatment: Results From a Single-Center Rural Veterans Hospital ,” published in the November 2024 issue of Infectious ...
Smelly urine is another UTI symptom. Health Shots got in touch with pediatric surgeon and pediatric urologist Dr Antony Robert Charles, to understand the various home remedies for the prevention of ...
SPR206 is an investigational, intravenously administered next-generation polymyxin that has shown antibiotic activity against MDR Gram-negative pathogens, including carbapenem-resistant ...
The global urinary antibacterial and antiseptic pharmaceuticals market is projected to grow at a robust Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period, driven by increasing ...
Sulopenem was superior to amoxicillin/clavulanate and ciprofloxacin in treating antimicrobial resistant uncomplicated urinary tract infections. The antibiotic was ...